|
2020
|
Invention
|
Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy.
Di... |
|
|
Invention
|
Fractionated dosing of a phospholipid ether analog for the treatment of cancer.
Disclosed herein... |
|
|
Invention
|
Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy. Dis... |
|
|
Invention
|
Fractionated dosing of a phospholipid ether analog for the treatment of cancer. Disclosed herein ... |
|
|
Invention
|
Phospholipid ether conjugates as cancer-targeting drug vehicles.
Disclosed herein are therapeuti... |
|
|
Invention
|
Phospholipid ether conjugates as cancer-targeting drug vehicles. Disclosed herein are therapeutic... |
|
2018
|
Invention
|
Phospholipid ether analogs as cancer-targeting drug vehicles. The present invention is directed t... |
|
2017
|
Invention
|
Phospholipid ether analogs for the identification and isolation of circulating tumor cells. The p... |
|
|
Invention
|
Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells.... |
|
2015
|
Invention
|
Phospholipid ether analogs as cancer-targeting drug vehicles. The present invention is dire... |
|
2014
|
Invention
|
Phospholipid analogs as diapeutic agents and methods thereof. The present invention provides meth... |
|
|
Invention
|
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof. The ... |
|
|
Invention
|
Fluorescent phospholipid ether compounds, compositions, and methods of use. The invention general... |
|
2006
|
Invention
|
Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum an... |
